232 related articles for article (PubMed ID: 20883779)
1. Phytantriol-based inverted type bicontinuous cubic phase for vascular embolization and drug sustained release.
Han K; Pan X; Chen M; Wang R; Xu Y; Feng M; Li G; Huang M; Wu C
Eur J Pharm Sci; 2010 Dec; 41(5):692-9. PubMed ID: 20883779
[TBL] [Abstract][Full Text] [Related]
2. Characterisation of bicontinuous cubic liquid crystalline systems of phytantriol and water using cryo field emission scanning electron microscopy (cryo FESEM).
Rizwan SB; Dong YD; Boyd BJ; Rades T; Hook S
Micron; 2007; 38(5):478-85. PubMed ID: 17011783
[TBL] [Abstract][Full Text] [Related]
3. Phytantriol based liquid crystal provide sustained release of anticancer drug as a novel embolic agent.
Qin L; Mei L; Shan Z; Huang Y; Pan X; Li G; Gu Y; Wu C
Drug Dev Ind Pharm; 2016; 42(2):307-16. PubMed ID: 26035332
[TBL] [Abstract][Full Text] [Related]
4. Impurities in commercial phytantriol significantly alter its lyotropic liquid-crystalline phase behavior.
Dong YD; Dong AW; Larson I; Rappolt M; Amenitsch H; Hanley T; Boyd BJ
Langmuir; 2008 Jun; 24(13):6998-7003. PubMed ID: 18522450
[TBL] [Abstract][Full Text] [Related]
5. Evaluating the link between self-assembled mesophase structure and drug release.
Phan S; Fong WK; Kirby N; Hanley T; Boyd BJ
Int J Pharm; 2011 Dec; 421(1):176-82. PubMed ID: 21963475
[TBL] [Abstract][Full Text] [Related]
6. Phytantriol and glyceryl monooleate cubic liquid crystalline phases as sustained-release oral drug delivery systems for poorly water soluble drugs I. Phase behaviour in physiologically-relevant media.
Nguyen TH; Hanley T; Porter CJ; Larson I; Boyd BJ
J Pharm Pharmacol; 2010 Jul; 62(7):844-55. PubMed ID: 20636872
[TBL] [Abstract][Full Text] [Related]
7. Liquid crystalline systems of phytantriol and glyceryl monooleate containing a hydrophilic protein: Characterisation, swelling and release kinetics.
Rizwan SB; Hanley T; Boyd BJ; Rades T; Hook S
J Pharm Sci; 2009 Nov; 98(11):4191-204. PubMed ID: 19340889
[TBL] [Abstract][Full Text] [Related]
8. [Preparation and in vitro embolic efficiency evaluation of hydroxycamptothecine-loaded liquid embolic agent].
Qin LZ; Zhang X; Wu LN; Zhang J; Pan X; Li G; Wu CB
Yao Xue Xue Bao; 2014 Jul; 49(7):1069-75. PubMed ID: 25233642
[TBL] [Abstract][Full Text] [Related]
9. A Novel Phytantriol-Based In Situ Liquid Crystal Gel for Vaginal Delivery.
Jie H; Liu L; Shuangying G; Xingqi W; Rongfeng H; Yong Z; Chunling T; Mengqiu X; Xiaoqin C
AAPS PharmSciTech; 2019 May; 20(5):185. PubMed ID: 31062112
[TBL] [Abstract][Full Text] [Related]
10. Bicontinuous cubic liquid crystals as sustained delivery systems for peptides and proteins.
Rizwan SB; Boyd BJ; Rades T; Hook S
Expert Opin Drug Deliv; 2010 Oct; 7(10):1133-44. PubMed ID: 20858165
[TBL] [Abstract][Full Text] [Related]
11. Bulk and dispersed aqueous phase behavior of phytantriol: effect of vitamin E acetate and F127 polymer on liquid crystal nanostructure.
Dong YD; Larson I; Hanley T; Boyd BJ
Langmuir; 2006 Nov; 22(23):9512-8. PubMed ID: 17073473
[TBL] [Abstract][Full Text] [Related]
12. Thermomyces lanuginosus lipase in the liquid-crystalline phases of aqueous phytantriol: X-ray diffraction and vibrational spectroscopic studies.
Misiūnas A; Talaikyte Z; Niaura G; Razumas V; Nylander T
Biophys Chem; 2008 May; 134(3):144-56. PubMed ID: 18329781
[TBL] [Abstract][Full Text] [Related]
13. Self-assembled multicompartment liquid crystalline lipid carriers for protein, peptide, and nucleic acid drug delivery.
Angelova A; Angelov B; Mutafchieva R; Lesieur S; Couvreur P
Acc Chem Res; 2011 Feb; 44(2):147-56. PubMed ID: 21189042
[TBL] [Abstract][Full Text] [Related]
14. Controlling nanostructure and lattice parameter of the inverse bicontinuous cubic phases in functionalised phytantriol dispersions.
Fraser SJ; Mulet X; Hawley A; Separovic F; Polyzos A
J Colloid Interface Sci; 2013 Oct; 408():117-24. PubMed ID: 23928485
[TBL] [Abstract][Full Text] [Related]
15. Development and evaluation of liquid embolic agents based on liquid crystalline material of glyceryl monooleate.
Du LR; Lu XJ; Guan HT; Yang YJ; Gu MJ; Zheng ZZ; Lv TS; Yan ZG; Song L; Zou YH; Fu NQ; Qi XR; Fan TY
Int J Pharm; 2014 Aug; 471(1-2):285-96. PubMed ID: 24858389
[TBL] [Abstract][Full Text] [Related]
16. Using a selective cadmium-binding peplipid to create responsive liquid crystalline nanomaterials.
Liu Q; Wang J; Dong YD; Boyd BJ
J Colloid Interface Sci; 2015 Jul; 449():122-9. PubMed ID: 25554088
[TBL] [Abstract][Full Text] [Related]
17. Stimuli responsive liquid crystals provide 'on-demand' drug delivery in vitro and in vivo.
Fong WK; Hanley T; Boyd BJ
J Control Release; 2009 May; 135(3):218-26. PubMed ID: 19331865
[TBL] [Abstract][Full Text] [Related]
18. Preparation and evaluation of phytantriol liquid crystal as a liquid embolic agent.
Fang X; Shen A
Pharm Dev Technol; 2020 Jun; 25(5):610-616. PubMed ID: 32008407
[TBL] [Abstract][Full Text] [Related]
19. Phytantriol-based in situ liquid crystals with long-term release for intra-articular administration.
Chen Y; Liang X; Ma P; Tao Y; Wu X; Wu X; Chu X; Gui S
AAPS PharmSciTech; 2015 Aug; 16(4):846-54. PubMed ID: 25573438
[TBL] [Abstract][Full Text] [Related]
20. In Vivo Formation of Cubic Phase in Situ after Oral Administration of Cubic Phase Precursor Formulation Provides Long Duration Gastric Retention and Absorption for Poorly Water-Soluble Drugs.
Pham AC; Hong L; Montagnat O; Nowell CJ; Nguyen TH; Boyd BJ
Mol Pharm; 2016 Jan; 13(1):280-6. PubMed ID: 26567591
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
